GlassScriptPhysician profile
Douglas Miyazaki
NPI 1053352435
$13,972.33
in general payments reported to CMS, 2019-2025
11 companies · $566 in 2025
The $566 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,182 · 2020: $185 · 2021: $2,178 · 2022: $1,007 · 2023: $2,094 · 2024: $760 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,220 · Consulting Fee: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,219.99 |
| Consulting Fee | $1,200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $10,143.50 | 2019-2025 | Altis, Saffron, Supris |
| Axonics, INC. | $2,657.29 | 2021-2024 | Axonics, Bulkamid |
| Boston Scientific Corporation | $388.56 | 2020-2025 | Lumenis Pulse 120h, Axonics, Upsylon |
| Swan Valley Medical Incorporated | $195.69 | 2021-2022 | |
| Medtronic USA, INC. | $154.39 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $138.81 | 2019 | |
| Ferring Pharmaceuticals INC. | $92.06 | 2019 | |
| Abbvie INC. | $86.07 | 2024-2025 | |
| Medtronic, INC. | $83.11 | 2022 | |
| Ethicon US, LLC | $22.59 | 2022 | |
| Ambu INC. | $10.26 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Miyazaki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.